NDC 68083-175
Regadenoson
Regadenoson
Regadenoson is a Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Gland Pharma Limited. The primary component is Regadenoson.
| Product ID | 68083-175_549593f6-8cfc-4182-8f3c-a60870187d8f |
| NDC | 68083-175 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Regadenoson |
| Generic Name | Regadenoson |
| Dosage Form | Injection, Solution |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 2022-07-12 |
| Marketing Category | ANDA / |
| Application Number | ANDA207320 |
| Labeler Name | Gland Pharma Limited |
| Substance Name | REGADENOSON |
| Active Ingredient Strength | 0 mg/mL |
| Pharm Classes | Adenosine Receptor Agonists [MoA], Pharmacologic Cardiac Stress Test Agent [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |